Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 22Terminated 7Recruiting 5Active not recruiting 3Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 76Thoracic 11Genitourinary 6Breast 6Dermatologic 5Gynecologic 3Gastrointestinal 3CNS 3Sarcoma 2Other solid neoplasm 2Other 2Lymphoid 1Endocrine 1

Conditions

Lymphoma 127Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Lymphoma, Non-Hodgkin 83Lymphoma, Follicular 76Lymphoma, Large B-Cell, Diffuse 71Leukemia 60Lymphoma, Mantle-Cell 51Burkitt Lymphoma 47Hodgkin Disease 44Leukemia, Myeloid, Acute 42Lymphoma, B-Cell, Marginal Zone 41Lymphoma, B-Cell 39Recurrence 38Lymphoma, T-Cell, Cutaneous 27Mycosis Fungoides 26Myelodysplastic Syndromes 25Waldenstrom Macroglobulinemia 24Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24Multiple Myeloma 21Lymphoma, Large-Cell, Immunoblastic 21Lymphoma, Large-Cell, Anaplastic 21Sezary Syndrome 19Neoplasms 19Hematologic Neoplasms 18Myeloproliferative Disorders 17Lymphoma, Extranodal NK-T-Cell 16Leukemia, Myelomonocytic, Chronic 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Leukemia, Biphenotypic, Acute 14

Interventions

Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Squamous Cell Carcinoma of Head and Neck × Lymphoid × Clear all
NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Presage Biosciences

Phase EARLY_PHASE1 Withdrawn
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡